Secbutonitazene

Last updated

Secbutonitazene
Secbutylnitazene structure.png
Identifiers
  • 2-{[4-(but-2-yl)oxyphenyl]methyl}-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole
CAS Number
PubChem CID
Chemical and physical data
Formula C24H32N4O3
Molar mass 424.545 g·mol−1
3D model (JSmol)
  • CCC(C)OC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-]
  • InChI=1S/C24H32N4O3/c1-5-18(4)31-21-11-8-19(9-12-21)16-24-25-22-17-20(28(29)30)10-13-23(22)27(24)15-14-26(6-2)7-3/h8-13,17-18H,5-7,14-16H2,1-4H3
  • Key:NOIMENQCHUDEKZ-UHFFFAOYSA-N

Secbutonitazene is a benzimidazole derivative which has been sold as a designer drug. It has opioid effects similar to related compounds, having slightly lower potency than metonitazene in vitro, but still more potent than fentanyl. [1] [2]

See also

References

  1. ↑ Hollerbach AL, Lin VS, Ibrahim YM, Ewing RG, Metz TO, Rodda KE (July 2024). "Elucidating the Gas-Phase Behavior of Nitazene Analog Protomers Using Structures for Lossless Ion Manipulations Ion Mobility-Orbitrap Mass Spectrometry". Journal of the American Society for Mass Spectrometry. 35 (7): 1609–1621. Bibcode:2024JASMS..35.1609H. doi:10.1021/jasms.4c00200. OSTI   2479690. PMID   38907730.
  2. ↑ Vandeputte MM, Glatfelter GC, Walther D, Layle NK, St Germaine DM, Ujváry I, et al. (December 2024). "Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice". Pharmacological Research. 210 107503. doi: 10.1016/j.phrs.2024.107503 . PMC  11655282. PMID   39521025.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.